Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Azenta, Inc. (AZTA)

57.79   -0.72 (-1.23%) 11-25 13:00
Open: 57.56 Pre. Close: 58.51
High: 58.465 Low: 57.54
Volume: 207,399 Market Cap: 4,335(M)

Technical analysis

as of: 2022-11-25 1:55:22 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 73.56     One year: 85.91
Support: Support1: 49.11    Support2: 40.54
Resistance: Resistance1: 62.97    Resistance2: 73.56
Pivot: 51.52
Moving Average: MA(5): 57.66     MA(20): 49.74
MA(100): 54.05     MA(250): 71.33
MACD: MACD(12,26): 3.7     Signal(9): 2.6
Stochastic oscillator: %K(14,3): 77.4     %D(3): 76.2
RSI: RSI(14): 66.3
52-week: High: 110.72  Low: 37.61
Average Vol(K): 3-Month: 885 (K)  10-Days: 1,270 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ AZTA ] has closed below upper band by 28.1%. Bollinger Bands are 120.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 60.27 - 60.5 60.5 - 60.76
Low: 57.8 - 58.05 58.05 - 58.33
Close: 58.05 - 58.45 58.45 - 58.9

Company Description

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

Headline News

Wed, 23 Nov 2022
Health Care Sector Update for 11/23/2022: MESO, XERS, HZNP, AZTA, XLV, IBB - Nasdaq

Wed, 23 Nov 2022
Azenta Inc. Sets $500 Million Accelerated Stock Buyback >AZTA - MarketWatch

Wed, 23 Nov 2022
Azenta enters $500M accelerated share repurchase agreement (NASDAQ:AZTA) - Seeking Alpha

Tue, 15 Nov 2022
Healthcare Stocks on the Move Tuesday: FDMT, AZTA, DRIO, XGN, RVPHW, TFFP, TWST, HSCS - InvestorsObserver

Tue, 15 Nov 2022
Is it a Good Time to Buy Azenta (AZTA) Stock? - Yahoo Finance

Tue, 15 Nov 2022
Pre-market Movers: AZTA, PEGY, POWW, PRI, SHLS… - Nasdaq

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 75 (M)
Shares Float 73 (M)
% Held by Insiders 1.5 (%)
% Held by Institutions 100.2 (%)
Shares Short 3,450 (K)
Shares Short P.Month 3,440 (K)

Stock Financials

EPS 29.65
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 45.15
Profit Margin (%) 383.9
Operating Margin (%) -4.4
Return on Assets (ttm) -0.6
Return on Equity (ttm) -0.5
Qtrly Rev. Growth 0
Gross Profit (p.s.) 3.4
Sales Per Share 7.4
EBITDA (p.s.) 0.39
Qtrly Earnings Growth 0
Operating Cash Flow -466 (M)
Levered Free Cash Flow -479 (M)

Stock Valuations

PE Ratio 1.94
PEG Ratio 9.5
Price to Book value 1.27
Price to Sales 7.8
Price to Cash Flow -9.31

Stock Dividends

Dividend 0.1
Forward Dividend 0
Dividend Yield 0.1%
Dividend Pay Date 2021-12-22
Ex-Dividend Date 2021-12-01
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.